Deep brain stimulation can improve symptoms of OCD by up to 50% and provide substantial improvements in two out of three sufferers.
Deep brain stimulation of the nucleus accumbens helps control symptoms of binge eating disorder and assists in weight loss.
Deep brain stimulation applied to a small brain area associated with reward and motivation resulted in metabolic brain changes over 12 months post-implantation and alleviated some symptoms of depression for those with treatment-resistant depression.
Using lesion network mapping, researchers identified brain circuits associated with addiction remission. The findings provide a new target for the development of treatments for addiction.
A new computer model shows the beneficial effects of deep brain stimulation arise from how it interrupts the cycle promoting runway beta in a circuit loop between the subthalamic nucleus and striatum.
Researchers report the optimal target for brain stimulation depends on the type of dystonia being treated.
Combining deep-brain stimulation with intracranial EEG, researchers achieved an individualized understanding of specific brain networks that contributed to an individual's depression symptoms and identified stimulation patterns best suited to each patient for symptom relief.
A new, improved DBS technique that targets specific subpopulations of neurons in the globus pallidus with short bursts of stimulation shows promising results as a treatment for Parkinson's disease.
A modified deep brain stimulation devise that delivers on-demand stimulation when it recognizes changes in brain patterns provides immediate and long-term relief for depression sufferers.
Researchers report self-perception does not diminish nor does an individual's personality change as a result of closed-loop brain stimulation brain implants for the treatment of epilepsy.
Deep brain stimulation appears to be safe, effective, and provides symptom improvements for at least one year in patients with treatment-resistant schizophrenia.
Researchers have successfully recorded brain signatures of movement symptoms and deep brain stimulation of Parkinson's patients in real time. The findings could lay the groundwork for personalize therapies for those with the neurodegenerative disease.
